Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
12/12/18 8-K Current report filing
Documents
11
11/13/18 8-K Current report filing
Documents
13
11/13/18 10-Q Quarterly report pursuant to Section 13 or 15(d) 45
10/29/18 424B3 Prospectus filed pursuant to Rule 424(b)(3) 18
10/26/18 EFFECT Notice of Effectiveness 1
10/25/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
10/25/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
10/25/18 S-1/A General form of registration statement for all companies including face-amount certificate companies
Documents
13
10/24/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
10/23/18 UPLOAD SEC-generated letter
Documents
1
RSS